October 3, 2025  -  InvestmentInvestment Round-upsNews

Women’s Health Investment Round-up (September 2025)

Investment

Midi Helath raises $50M Series C for its menopause platform.

BeSound raises $6.8M to expand breast cancer screening for dense tissue and younger women.

Mamaya Health raises $3M to expand family-focused mental health platform.

Neura Health raises a $11.4M Series A for its virtual neurology platform.

Visana Health raises a $24M Series A to scale its virtual-first women's health clinic.

Seven Starling raises $8M to expand its women's mental health platform in the US.

Parento raises $5.9M in seed II funding to expand its paid parental leave insurance for small businesses.

Evela Health completes a €2M funding round to transform menopause care in the German-speaking markets.

Conceivable Life Sciences raises a $50M Series A for the US launch of its automated IVF lab.

Diana Health raises a $55M Series C to expand its hospital partnered women's health network.

Lovu Health raises a $8M Series A for its AI-powered maternal health platform.

Prenaital secures $1.57M to advance AI-powered prenatal screening technology.

Fraiya launches a new NHS trial of AI pregnancy ultrasounds after £3.5 million in funding.

BoobyBiome raises £2.5 million to preserve breast milk's hidden microbiome.

Salient Bio raises £2.35 million to launch its IBD diagnostic test and focus on women's health.

Danish startup Lapee raises €800K for women's public urinals.

Grants

PS Fertility receives $1.7 million NIH grant for its male fertility diagnostic test.

Rapidemic secures a $2.7M Gates Foundation grant for its rapid STI diagnostics.

IMMA Health secures a $1.6M grant for its at-home fertility monitoring device.

Hormona receives a £100K grant to develop AI tools for gfaster perimenopause diagnosis.

Acquisitions

Remedy Meds acquires Thirty Madison in a $500M all stock-deal.

Zepp Health acquires Wild.AI assets to integrate hormone-informed coaching into Amazfit devices.

Other

ICONIQ Impact launches a new Women's Health Co-Lab targeting $100 million in funding.

Wellcome Leap and Pivotal commit $100 million to research on conditions that disproportionally affect women.